An interventional study of AI-guided personalized rehabilitation in Lung Neoplasms, sponsored by Peking University Cancer Hospital & Institute. Enrolling by invitation at 1 site in China. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-04.
Sponsored by Peking University Cancer Hospital & Institute · Not applicable, Interventional, and Supportive care
This study will evaluate whether a generative artificial intelligence (AI)-based rehabilitation support system can help older adults with lung cancer recover after lung surgery. Eligible participants aged 65 years or older who are scheduled for video-assisted thoracoscopic surgery (VATS) will be randomly assigned to receive either personalized perioperative rehabilitation guidance through the AI-based system or usual rehabilitation guidance. The system will provide guidance on exercise, nutrition, and psychological well-being before surgery and during recovery, and participants may report symptoms for follow-up guidance. The study will compare lung function and quality of life between the groups. It will also assess exercise tolerance, emergency department visits, hospital readmissions, and events related to use of the system.
7,343 studies on the registry are indexed under Lung Neoplasms; 1,562 are open to participants now.
This study's planned enrollment of 150 is above the median of 60 across 5,348 interventional studies indexed under Lung Neoplasms.
Browse Lung Neoplasms studies →Peking University Cancer Hospital & Institute is the lead sponsor of 268 studies on the registry; 129 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: AI-guided personalized rehabilitation
Participants will use a mobile-based generative AI rehabilitation support system before and after surgery. Before surgery, the system will provide daily reminders and personalized guidance for home-based exercise and provide support related to nutrition and psychological well-being. After surgery, participants will report relevant symptoms, such as pain, shortness of breath, cough, or fever, and receive interactive rehabilitation guidance adjusted according to their reported condition. The system is supervised by the clinical team.
MDASI-LC quality-of-life scores
Quality of life will be assessed using the MD Anderson Symptom Inventory for Lung Cancer (MDASI-LC), including 6 items on symptom interference with daily life and 16 items measuring symptom severity. The scores will be collected using an online questionnaire.
Time frame: Before surgery; 1 week and 2 weeks after hospital discharge; and at the 1-month postoperative return visit
Forced Expiratory Volume in 1 Second (FEV1)
FEV1 will be measured using a handheld spirometer.
Time frame: Before surgery, on the day of hospital discharge, and at the 1-month postoperative return visit
Forced Vital Capacity (FVC)
FVC will be measured using a handheld spirometer.
Time frame: Before surgery; on the day of hospital discharge; and at the 1-month postoperative return visit.
Maximum Voluntary Ventilation (MVV)
MVV will be measured using a handheld spirometer.
Time frame: Before surgery; on the day of hospital discharge; and at the 1-month postoperative return visit.
Borg Rating of Perceived Exertion During Aerobic Exercise
Perceived exertion during aerobic exercise will be assessed using the Borg Rating of Perceived Exertion (RPE) Scale. Scores range from 6 to 20, with higher scores indicating greater perceived exertion.
Time frame: Before surgery and at postoperative weeks 1, 2, 3, and 4.
Emergency Department Visits
'The number of participants with an emergency department visit will be recorded.
Time frame: From randomization through 24 months after surgery.
Hospital Readmissions
The number of participants readmitted to the hospital will be recorded.
Time frame: From randomization through 24 months after surgery.
Adverse Events Related to the AI-Based Rehabilitation System
The number of participants experiencing adverse events related to use of the system will be recorded, including injuries associated with excessive exercise, falls, eye strain, or other harm related to system use.
Time frame: From first use of the system through 24 months after surgery.
Plan to share: No
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peking University Cancer Hospital & Institute →